Chemotherapy Combined With CIK Treating Colon Cancer

NCT03084809 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Cytokine-induced Killer Cells
Postoperative Complications
Survival

Interventions

DRUG: Cytokine-induced killer cells+ FOLFOX4
DRUG: FOLFOX4

Sponsor

China Meitan General Hospital